← SynDRA
SB-747651A
SynDRA canonical compound SYN1961049 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | AKT1 | AKT3 | ROCK1 | RPS6KA4 | RPS6KA5 | RPS6KB1 |
|---|
| Mechanism of action | kinase inhibitor |
|---|
All known targets
- AKT1
- AKT3
- ROCK1
- RPS6KB1
- RPS6KA4
- RPS6KA5
Mechanisms of action (all sources)
- kinase inhibitor
- AKT3 INHIBITOR
- ROCK1 INHIBITOR
- RPS6KB1 INHIBITOR
- AKT1 INHIBITOR
Cross-references
Synonyms
- CHEMBL188434
- compound 26
- SCHEMBL4719834
- GTPL8130
- BDBM24996
- oxadiazole-containing compound, 9
- MBCJUIJWPYUEBX-UHFFFAOYSA-N
- ZINC13998530
- NCGC00273984-05
- NCGC00273984-03
- SB-747651
- 4-{1-ethyl-7-[(piperidin-4-ylamino)methyl]-1H-imidazo[4,5-c]pyridin-2-yl}-1,2,5-oxadiazol-3-amine
- [2-(4-Amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-7-ylmethyl]-piperidin-4-yl-amine
Look up SB-747651A in the interactive SynDRA portal →